HEART PATHWAY Brian O’Neal, MD

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Rate of Obstructive Coronary Disease in Elective Diagnostic Cath Manesh R. Patel, MD Assistant Professor of Medicine Director Cath Lab Research – Duke.
OVERALL CATHETERIZATION LABORATORY NORMAL ANGIOGRAPHY RATE DOES NOT INCREASE WITH EMERGENCY ROOM ACTIVATION OF PRIMARY CORONARY INTERVENTION (PCI) FOR.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
The potential impact of adherence to a guideline on the utilization of head CT scans in traumatic head injury patients. Frederick K. Korley M.D.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Silent Ischemia STABLE CAD
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
TARGET and TACTICS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for.
Naotsugu Oyama, MD, PhD, MBA A Trial of PLATelet inhibition and Patient Outcomes.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Involving Patients with Low Risk Chest Pain in Discharge Decisions: A Multicenter Trial Erik P. Hess MD MSc.
Acute Coronary Syndrome
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Josephine Mak Waikato Cardiothoracic Unit Journal Club
Atherosclerotic Cardiovascular Heart Disease in Women
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
A Clinical profile of patients enrolled in the Pakistan ACS registry
18th Annual Primary Care and Cardiovascular Symposium
Myocardial Injury after Noncardiac Surgery and Association with Short Term Mortality Wilton A van Klei Anesthesiologist and acting chair Department Anesthesiology,
Risk Stratification of Chest Pain: Best Practices
The American College of Cardiology Presented by Dr. Adnan Kastrati
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Comparative Efficiency of Exercise Stress Testing With.
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
Cocaine-Related Chest Pain: The Year After
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
HOPE: Heart Outcomes Prevention Evaluation study
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Improving Care Processes for Patients with Possible Acute Coronary Syndrome (ICARE-ACS)
Rural Chest Pain Quality Improvement
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Intensive Observation Unit Careggi University Hospital, Firenze Italy
Systolic Blood Pressure Intervention Trial (SPRINT)
Quality Improvement Program: Chest Pain Outpatient Testing
Statins Evaluation in Coronary procedUres and REvascularization
Section A: Introduction
European Heart Association Journal 2007 April
European Society of Cardiology 2003
The following slides are based on a presentation at a Satellite Symposium in association with the Annual Cardiovascular Conference at Lake Louise, Alberta,
Advancing Acute Coronary Syndrome Assessment:
Invasive versus conservative treatment in unstable coronary syndromes
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
The European Society of Cardiology Presented by RJ De Winter
Erasmus MC, Thoraxcenter
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Global Registry of Acute Coronary Events: GRACE
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
ARISE Trial Aggressive Reduction of Inflammation Stops Events
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Maintenance of Long-Term Clinical Benefit with
Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire
Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.
Atlantic Cardiovascular Patient Outcomes Research Team
Principal recommendations
Presentation transcript:

HEART PATHWAY Brian O’Neal, MD Assistant Professor, UNC School of Medicine Wake Emergency Medicine Physicians, LLC

What’s The Problem? Each year, 8 to 10 million patients in the United States present to the emergency department with the chief complaint of chest pain. When caring for these patients, emergency physicians use liberal testing strategies to prevent missing an acute coronary syndrome (ACS). Why? Because ACS can kill you, we care about our patients, and we don’t want to get sued.

What’s The Problem? This pervasive over triage results in >50% of ED patients with acute chest pain receiving a comprehensive cardiac evaluation (serial cardiac biomarkers and stress testing or angiography) at a cost of $10 to 13 billion annually. Yet <10% of these patients are ultimately diagnosed with ACS.

So What To Do?.....

HEART PATHWAY Origination Developed by the European Society of Cardiology, the HEART score is a cardiovascular disease risk assessment and management tool aimed at supporting clinicians in optimizing individual cardiovascular risk reduction.

Origination Original framing of the score collected data from 12 European cohort studies (N=205,178) covering a wide geographic spread of countries at different levels of cardiovascular risk. The SCORE data contains some 3-million person-years of observation and 7,934 fatal cardiovascular events.

HEART Score Intended to help the provider predict the 6 week risk of a major adverse cardiac event (MACE). Comprised primarily of 5 factors History EKG Age Risk Factors Troponin Results

HEART Score Risk factors encompass: hypercholesterolemia, hypertension, diabetes mellitus, cigarette smoking, family history, obesity

HEART Score HEART score of 0-3 points, indicated a 6 week risk of MACE of 1.6%. Possibly early discharge. HEART score of 4-6 points, indicated a 6 week risk of MACE of 13%. HEART score ≥ 7 points, indicated a 6 week risk of MACE of 50%.

HEART Score/Pathway

What’s Some Of The Evidence??? Three Trials 1) A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 2) Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 3) The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department Int J Cardiology, 2013

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 Prospective randomized trial of patients presenting to 10 different Netherlands emergency departments with the chief complaint of chest pain. 2,388 patients were enrolled. All STEMIS were excluded. The HEART Score was compared to the TIMI and GRACE scores in their ability to diagnose AMI. Primary endpoint was the occurrence of major adverse cardiac events (MACE) in 6 weeks. Secondary endpoints The occurrence of AMI and death ACS The performance of a coronary angiogram

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013

What did they find? TIMI scores of 0-1, 6 week MACE was 2.8% A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 What did they find? TIMI scores of 0-1, 6 week MACE was 2.8% GRACE scores 0-60, 6 week MACE was 2.9% HEART score (NOT pathway) 0-3, 6 week MACE was 1.7%

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 What did they find?

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 Author’s Conclusion? The HEART score performed significantly better (p <0.001) as compared with TIMI and GRACE in the primary endpoint of MACE in 6 weeks. Not only did the HEART score perform statistically better, but it is the only of the three scores particularly designed to risk stratify patients in the emergency department as opposed to the inpatient cardiac care unit.

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 And….. The HEART Score performed statistically better than TIMI and GRACE (p <0.001) in all three secondary endpoints as well. The HEART Score retained its discriminative ability in three relevant subgroups in which ACS diagnosis can be tricky! Diabetics Females Elderly over 65 years of age

A Prospective Validation of the HEART Score for Chest Pain Patients At The Emergency Department, Int J Cardiology, 2013 And…… And….. This study used the HEART score, instead of the also prospectively validated HEART Pathway (HEART score with a 3 hour repeat troponin). Studies of the HEART Pathway among patients presenting with chest pain have demonstrated 99-100% sensitivity and 99-100% NPV for MACE at 30 days. (Mahler, "Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events?" Critical Pathway Cardiology, 2011; 10:128-133; PUBMED: 21989033)

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain Int J Cardiology, 2013

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 Retrospective study by Mahler (one of the main pioneers of the HEART score) of 1005 patients presenting to 18 different US EDs over a 2 year time period. Subjects had to be greater than 18 with symptoms suggestive of ACS starting within 6 hours, in whom the physician planned objective cardiac testing (i.e. the very low risk chest pain patients weren't even included in the sample study). Coronary angiography, CT coronary angiography, stress testing, cardiac MRI, or echo. Primary outcome was rate of ACS within 30 days of presentation defined as cardiac death, AMI, and unstable angina.

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 Definition of AMI was a typical rise and gradual fall of troponin with at least one of the following: ischemic symptoms, development of pathological ECG Q waves, ECG changes indicative of ischemia, or coronary revascularization. UA was defined by ischemia confirmed by ECG ST-segment changes with recurrent symptoms or a troponin elevation that did not meet AMI criteria with either >70% coronary stenosis on coronary angiography, or inducible ischemia with stress testing if catheterization was not performed.

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 The study evaluated the difference in clinical utility of three different pathways to identify acute chest pain patients able to be discharged early without stress testing or cardiac imaging with an acceptable miss rate of less than 1%: “Unstructured assessment” North American Chest Pain Rule (NACPR) Heart PATHWAY (HEART score with a 3 hour repeat troponin).

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 The study population had an ACS event at index visit or within 30 days of 22%. Unstructured assessment identified 13.5% of participants for early discharge with a 98% sensitivity for ACS. NACPR identified 4.4% for early discharge with 100% sensitivity for ACS. HEART pathway identified 20% for early discharge with a 99% sensitivity for ACS.

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013

Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 Interesting and scary Serial troponins alone at 0 and 3 hours had a sensitivity of 56% and would have missed 98 patients with ACS at 30 days in this study. Addition of a decision rule resulted in an absolute increase in sensitivity of 42-44% for 30 day ACS! But again, remember that in this study eligibility required patients identified by their providers as needing objective cardiac testing….. hence the high event rate of 22%.

Author’s Conclusions: Identifying Patients For Early Discharge: Performance of Decision Rules Among Patients With Acute Chest Pain, Int J Cardiology, 2013 Author’s Conclusions: Researchers concluded that the HEART pathway was better than the NACPR and simple physician judgment in deciding which patients could be safely discharged home without advanced cardiac testing without sacrificing any missed MACE cases at 30 days. Researcher went on to say that "the HEART pathway has demonstrated a miss rate of 0% and 0.2% in two separate analyses with over 2000 patients".

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge Circulation, 2015

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 Trial by Mahler again (Wake Forest Baptist Medical Center), randomizing 282 patients to either the HEART Pathway (HEART score with a 3 hour repeat troponin) or “usual care” (following ACC/AHA guidelines) in the treatment chest pain patients presenting to the ED. All STEMI’s were excluded

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 HEART PATHWAY ARM – For patients with a score of 0-3 and negative serial troponins, the physicians were encouraged to discharge their patients and have them follow up with their primary care providers. Score of 4 or more, or elevated troponin, they were encouraged to admit for observation or objective cardiac testing. Usual Care – providers were encouraged to follow the ACC/AHA guidelines.

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 Care delivered in both randomization arms was ultimately determined by provider discretion and not mandated by the trial protocol. The HEART Pathway was used by providers, in a manner consistent with its intent, as a decision aid rather than a substitute for clinical judgment. Patients randomized to the HEART Pathway received a second HEART score assessment by an attending physician study investigator blinded to the initial assessment by the patient’s attending physician. Based on their Institutional Review Board recommendations, if a disagreement occurred in which the attending provider determined the patient to be low-risk, but the study investigator found the patient to be high-risk, the attending provider was made aware of this discrepancy.

Secondary outcomes included The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 Primary outcome was the rate of objective cardiac testing within 30 days of presentation, defined as the proportion of patients receiving any stress testing modality, coronary computed tomographic angiography, or invasive coronary angiography at the index visit or within 30 days as well as the presence of a 30 day MACE event. Secondary outcomes included Early discharge rate Index LOS Cardiac-related recurrent ED visits and non-index hospitalization at 30 days. Early discharge was defined as discharge from the ED without objective cardiac testing. Hospitalization was defined as bedding a patient to an OU or inpatient ward in observation or inpatient status.

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 RESULTS: Patients randomized to the HEART Pathway had a 30-day objective cardiac testing rate of 56.7% (80/141) compared with a rate of 68.8% (97/141) in the usual care group: an absolute reduction of 12.1% (P=0.048). Early discharge occurred in 39.7% (56/141) of patients in the HEART Pathway arm compared with 18.4% (26/141): an absolute increase of 21.3% (P<0.001). Patients in the HEART Pathway group had a median LOS of 9.9 hours compared with 21.9 hours in the usual care group: a median reduction in LOS of 12 hours (P=0.013).

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 RESULTS: Within the HEART Pathway arm, 2.8% (4/141) had cardiac-related repeat ED visits compared with 4.3% (6/141) in the usual care arm (P=0.75). Cardiac-related non-index hospitalizations occurred in 3.6% (5/141) of patients in the HEART Pathway arm compared with 2.8% (4/141) in the usual care arm (P>0.999). No patients identified for early discharge had missed MACE in either group during the 30-day follow-up period. No patients identified as low-risk by the HEART Pathway had an index or non-index MACE. Index MACE occurred in 5.7% (8/141) patients in the HEART Pathway arm compared with 6.4% (9/141) in the usual care arm (P=1).

The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 RESULTS: Non-adherence to the HEART Pathway occurred in 29% (19/66) of low-risk patients and 13% of (9/75) high-risk patients. But NONE of the 19 low-risk patients had MACE at index or 30 days. Perfect adherence among high- and low-risk patients would have increased the early discharge rate to 46.8% (66/141).

In summary, following the HEART pathway in this study: The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 In summary, following the HEART pathway in this study: Objective cardiac testing at 30 days decreased by 12.1 percent Length of stay dropped by 12 hours Early discharges increased by 21.3% 6% of patients had a major adverse cardiac event (MACE) within 30 days but this occurred in NO patients that were discharged.

Furthermore, this group was not a “low” risk group! The HEART Pathway Randomized Trial - Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge, Circulation, 2015 Furthermore, this group was not a “low” risk group! Almost 20 percent of the study group enrolled had a previous history of MI, PCI, or CABG.

So What Are We Doing At Wakemed?